Skip to main
AUTL
AUTL logo

Autolus Therapeutics (AUTL)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Autolus Therapeutics (AUTL) Stock

About Autolus Therapeutics (AUTL)

Autolus Therapeutics Plc is a biopharmaceutical company, which engages in the development and commercialization of gene therapies. It uses proprietary and modular T cell programming technologies that are designed to recognize cancer cells, break down their defense mechanisms, and attack and kill these cells. The company was founded by Martin Pule in September 2014 and is headquartered in London, t...read more
Market cap$564.22M
Today's volume1.9M
Revenue (TTM)$9.01M
Avg. daily volume2.22M
EBITDA (TTM)-$259.08M
Open$2.05
Price / earnings ratio-2.37x
Today's range$2.05 - $2.18
Debt / equity83.84x
52 week range$1.11 - $5
5 year debt / equity68.62x
Beta (LTM)1.16x
Interest coverage-23.79x
Dividend & yield$0.00 (0.00%)
Current ratio9.21x
Ex-dividend date
Next earningsAug 7, 2025
Dividend payable date

Autolus Therapeutics Stock Rating

What analysts recommend for AUTL stock, on a scale from 1(buy) to 5(sell).
Strong Buy
Strong Buy 82%
Buy 9%
Hold 9%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 15, 2025, the market cap for AUTL stock is $564.22M

The current P/E ratio for AUTL stock is -2.37

The 52-week high for AUTL stock is $5. The current AUTL stock price $undefined is 100.00% below its 52-week high

The 52-week low for AUTL stock is $1.11. The current AUTL stock price $undefined has increased 100.00% from its 52-week low

No, the AUTL stock does not pay dividends to its shareholders

The target price for AUTL stock is $15.05 based on the average of what a group of analyst think AUTL stock could be worth at a future date. This is not a prediction by Public.com

How to buy AUTL stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in AUTL stock

    Navigate to the Explore page. Then, type AUTL into the search bar. When you see AUTL stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased AUTL stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Autolus Therapeutics Stock Earnings

The value each AUTL share was expected to gain vs. the value that each AUTL share actually gained.

Autolus Therapeutics (AUTL) reported Q1 2025 earnings per share (EPS) of -$0.26, meeting estimates of -$0.26 by 0.00%. In the same quarter last year, Autolus Therapeutics's earnings per share (EPS) was -$0.24. Autolus Therapeutics is expected to release next earnings on 08/07/2025, with an earnings per share (EPS) estimate of $0.

Buy Autolus Therapeutics (AUTL) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.